VAXON Biotech’s IP portfolio is composed of twelve patent families, all of which are either exclusively licensed from INSERM / IGR (Institut Gustave Roussy) or wholly owned by VAXON Biotech.

Twenty-eight patents have been granted (two in France, seven in Europe, seven in US, three in Japan, three in China, five in Canada and one in South Korea).